5-amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase investigated in biochemical assays, adipocyte cultures and mouse models of diet-induced obesity.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Small-molecule NNMT inhibitor
5-amino-1MQ abbreviates 5-amino-1-methylquinolinium. It is a synthetic small molecule, not an amino-acid peptide. Research on this particular quinolinium compound should be distinguished from studies of other NNMT inhibitors, which may have different selectivity, exposure and biological effects.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Nicotinamide N-methyltransferase, or NNMT, transfers a methyl group to nicotinamide. Inhibiting the enzyme can change the availability of nicotinamide and methyl-donor metabolites. Structure-activity work examined quinolinium binding at the substrate site, while subsequent cellular studies connected enzyme inhibition with changes in metabolic pools.
A medicinal-chemistry study compared related molecular scaffolds and substitutions using enzyme assays and computational docking. It established a framework for studying NNMT inhibition, while showing that closely related compounds can differ substantially in activity. [1]
Cell experiments with 5-amino-1MQ measured lower levels of the NNMT product 1-methylnicotinamide alongside altered NAD+ and methyl-donor availability. These are biochemical observations in cultured fat cells, rather than evidence that all tissues respond identically. [2]
A short mouse study reported reduced body weight and adipose-tissue measures without a corresponding reduction in food intake. It provided preclinical proof of concept, but its limited duration and animal setting constrain interpretation of efficacy and safety. [2]
Study topics describe the cited models, not established benefits of this catalog material.
The selected publications examine the molecule directly, rather than inferring its activity solely from NNMT genetics or a different inhibitor. They support its use as an experimental probe of metabolic regulation. They do not provide controlled human evidence for weight loss or metabolic treatment.
Cell permeability and biochemical selectivity do not establish human absorption or long-term safety. Short animal experiments cannot resolve effects of sustained NNMT inhibition across different organs. Claims about clinical benefit, lifespan or WYZ material quality would require separate evidence beyond these studies.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Quinolinium structure-activity relationships and substrate-site modeling.
Direct 5-amino-1MQ adipocyte and short-duration obese-mouse experiments.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
